Neoadjuvant therapy in non-small cell lung cancer: basis, promise, and challenges

Sukumar Kalvapudi, Yeshwanth Vedire, Sai Yendamuri, Joseph Barbi · 2023

Read Neoadjuvant therapy in non-small cell lung cancer: basis, promise, and challenges by Sukumar Kalvapudi, Yeshwanth Vedire, Sai Yendamuri, Joseph Barbi (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10739417.txt.

Description

Sukumar Kalvapudi, Yeshwanth Vedire, Sai Yendamuri, and Joseph Barbi review treatment given before surgery for non-small cell lung cancer, in this 2023 review. Early lung cancer still kills too often even after surgery and follow-up therapy. Pre-surgery treatment attacks stray tumor cells early and can shrink tumors enough to make removal possible.

The authors surveyed over one hundred papers and seventeen running trials. Trial evidence says the approach is as safe as, and sometimes better than, therapy after surgery. New stand-in measures, like how much tumor dies in the removed tissue, let trials finish faster. Risks remain: side effects or resistance can cost the window for cure. The authors urge larger randomized trials.

Catalog record

CREATORSukumar Kalvapudi, Yeshwanth Vedire, Sai Yendamuri, Joseph Barbi
YEAR2023
COLLECTIONPAPERS
FORMATTXT
FILE SIZE61 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC10739417

Browse the full library · About the Tower of Babel